Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-18-052491
Filing Date
2018-09-27
Accepted
2018-09-27 18:03:14
Documents
1
Period of Report
2018-09-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6645
  Complete submission text file 0001209191-18-052491.txt   7978
Mailing Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080
Business Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA INC (Issuer) CIK: 0001382101 (see all company filings)

EIN.: 452441988 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 10990 WILSHIRE BLVD, SUITE 1200 LOS ANGELES CA 90024
Business Address
MOLINA ARTURO MD (Reporting) CIK: 0001398940 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38662 | Film No.: 181092064